NTN1 and ischemic stroke: A case–control study of 180 ischemic stroke patients reported that individuals in the highest tertile of serum netrin-1 on admission had approximately threefold greater odds of achieving good functional outcomes (mRS ≤ 2 at 3 months) compared with those in the lowest tertile, even after adjusting for age and baseline NIHSS [49].